ปรับปรุง : 7/03/2018
สถิติผู้เข้าชม:6504251 การเปิดหน้าเว็บ:9345038 Online User Last 1 hour (0 users)
Task force to strengthen Indian pharma industry
16 มีนาคม 2554
Date: 16 March 2011
New Delhi, A 12-member task force that will evolve strategies for making India
a hub for drug discovery and research was set up under the chairmanship of
health research secretary V.M. Katoch, a health ministry release said here
Tuesday.
Health and Family Welfare Minister Ghulam Nabi Azad constituted the task force
to evolve a long-term strategy for addressing various issues faced by the
Indian pharma industry, the release said. The task force has been asked to
submit its report within three months.
The task force, to be co-chaired by director general health services R.K.
Srivastava, will draw members from the National Pharmaceutical Pricing
Authority and Department of Industry Policy and Promotion, apart from several
industry lobbies.
The Drug Controller General of India will be the member-secretary of the task
force. The chairman of the task force has also been given the powers to co-opt
any other expert in the relevant area as is considered necessary, the release
added.
Among the terms of reference would be to evolve a short, medium and long-term
policy and strategy to make India a hub for drug discovery, research and
development.
It will also evolve strategies to further the interests of Indian pharma
industry in the light of issues related to intellectual property rights and
recommend strategies to capitalise the opportunity of $60 to $80 billion drugs
going off-patent over the next five years.
The task force will also evolve policy measures to assure national drugs
security by promoting indigenous production of bulk drugs, preventing takeover
of Indian pharma industry by multi-national corporations, drug pricing,
promotion of generic drugs and recommend measures to assure adequate availability
of quality generic drugs at affordable prices.
The move for setting up the task force comes in the wake of a meeting the
minister had with drug manufacturers in Mumbai and Hyderabad, where they had
requested him to constitute a task force to prepare a long-term strategy for
strengthening of the drug sector in the country and take all aspects of the
drug industry on board, including those concerning medical devices, clinical
research organisations, and research and development labs.